Literature DB >> 19100702

CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity.

Paulus Mrass1, Ichiko Kinjyo, Lai Guan Ng, Steven L Reiner, Ellen Puré, Wolfgang Weninger.   

Abstract

Although T lymphocytes are constitutively nonadherent cells, they undergo facultative polarity during migration and upon interaction with cells presenting cognate antigen, suggesting that cell polarity might be critical for target cell destruction. Using two-photon imaging of tumor-infiltrating T lymphocytes, we found that CD44, a receptor for extracellular matrix proteins and glycosaminoglycans, was crucial for interstitial T cell navigation and, consequently, efficient tumor cell screening. CD44 functioned as a critical regulator of intratumoral movement by stabilizing cell polarity in migrating T cells, but not during target cell interactions. Stable anterior-posterior asymmetry was maintained by CD44 independently of its extracellular domain. Instead, migratory polarity depended on the recruitment of ezrin, radixin, moesin (ERM) proteins by the intracellular domain of CD44 to the posterior cellular protrusion. Our results formally demonstrate that CD44-dependent T lymphocyte locomotion within target sites represents an essential immunologic checkpoint that determines the potency of T cell effector functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100702      PMCID: PMC2757129          DOI: 10.1016/j.immuni.2008.10.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  40 in total

Review 1.  Intravital imaging of cell movement in tumours.

Authors:  John Condeelis; Jeffrey E Segall
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 2.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

Review 3.  New views of the immunological synapse: variations in assembly and function.

Authors:  Jordan Jacobelli; Pietro G Andres; Judie Boisvert; Matthew F Krummel
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

Review 4.  The role of the secretory immunological synapse in killing by CD8+ CTL.

Authors:  Jane C Stinchcombe; Gillian M Griffiths
Journal:  Semin Immunol       Date:  2003-12       Impact factor: 11.130

Review 5.  Extracellular matrix of ovarian tumors.

Authors:  Carmela Ricciardelli; Raymond J Rodgers
Journal:  Semin Reprod Med       Date:  2006-09       Impact factor: 1.303

Review 6.  In vivo imaging of lymphocyte trafficking.

Authors:  Cornelia Halin; J Rodrigo Mora; Cenk Sumen; Ulrich H von Andrian
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 7.  Dynamic imaging of the immune system: progress, pitfalls and promise.

Authors:  Ronald N Germain; Mark J Miller; Michael L Dustin; Michel C Nussenzweig
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

8.  Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.

Authors:  Thorsten R Mempel; Mikael J Pittet; Khashayarsha Khazaie; Wolfgang Weninger; Ralph Weissleder; Harald von Boehmer; Ulrich H von Andrian
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 9.  Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.

Authors:  Paulus Mrass; Wolfgang Weninger
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 10.  Molecular aspects of stromal-parenchymal interactions in malignant neoplasms.

Authors:  Attila Zalatnai
Journal:  Curr Mol Med       Date:  2006-09       Impact factor: 2.222

View more
  43 in total

Review 1.  Analysing immune cell migration.

Authors:  Joost B Beltman; Athanasius F M Marée; Rob J de Boer
Journal:  Nat Rev Immunol       Date:  2009-10-16       Impact factor: 53.106

2.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 3.  Leukocyte migration in the interstitial space of non-lymphoid organs.

Authors:  Wolfgang Weninger; Maté Biro; Rohit Jain
Journal:  Nat Rev Immunol       Date:  2014-03-07       Impact factor: 53.106

4.  Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Paul L Bollyky; Gerald T Nepom; Thomas N Wight
Journal:  Matrix Biol       Date:  2011-11-20       Impact factor: 11.583

5.  Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.

Authors:  Juhua Zhou; Prakash Nagarkatti; Yin Zhong; Mitzi Nagarkatti
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

Review 6.  Intravital imaging of anti-tumor immune response and the tumor microenvironment.

Authors:  Tomasz Zal; Grzegorz Chodaczek
Journal:  Semin Immunopathol       Date:  2010-07-22       Impact factor: 9.623

Review 7.  T cell migration, search strategies and mechanisms.

Authors:  Matthew F Krummel; Frederic Bartumeus; Audrey Gérard
Journal:  Nat Rev Immunol       Date:  2016-02-08       Impact factor: 53.106

8.  Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.

Authors:  Cheng-Rui Li; Erin E Mueller; Linda M Bradley
Journal:  Immunol Lett       Date:  2014-10-22       Impact factor: 3.685

9.  Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.

Authors:  Eri Takahashi; Osamu Nagano; Takatsugu Ishimoto; Toshifumi Yae; Yoshimi Suzuki; Takeshi Shinoda; Satoshi Nakamura; Shinichiro Niwa; Shun Ikeda; Hisashi Koga; Hidenobu Tanihara; Hideyuki Saya
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

10.  Intrinsic defects in CD8 T cells with aging contribute to impaired primary antiviral responses.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Exp Gerontol       Date:  2013-03-06       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.